Ameriprise’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,874
| Closed | -$24K | – | 4060 |
|
2024
Q4 | $24K | Buy |
+1,874
| New | +$24K | ﹤0.01% | 4014 |
|
2023
Q4 | – | Sell |
-2,247
| Closed | -$66.1K | – | 3947 |
|
2023
Q3 | $66.1K | Buy |
+2,247
| New | +$66.1K | ﹤0.01% | 3824 |
|
2023
Q2 | – | Sell |
-11,347
| Closed | -$536K | – | 3961 |
|
2023
Q1 | $536K | Buy |
+11,347
| New | +$536K | ﹤0.01% | 3406 |
|